Publication | Closed Access

MAFF confers vulnerability to cisplatin-based and ionizing radiation treatments by modulating ferroptosis and cell cycle progression in lung adenocarcinoma

Cell Cycle ProgressionRadiation TherapyMedicineLung AdenocarcinomaCancer BiologyMaff Confers VulnerabilityCancer TreatmentRadiation OncologyOncologyCell BiologyLung CancerTumor Biology